Frank V. Schraml, MD
Frank V. Schraml, MD

Frank V. Schraml, MD

Professor
School of Medicine, Phoenix Campus

Academic Appointments

Department

  • Radiology (Phoenix)

Position

  • Professor

Publications and Presentations

Publications

  • Schmieder S, Schraml F. CSF-oma Identification With Nuclear Medicine Shunt-o-Gram., Clinical Nuclear Medicine, Volume 44, Issue 5, 399-400, 2019
  • Schmieder S, Schraml F. CSF-oma Identification With Nuclear Medicine Shunt-o-Gram., Clinical Nuclear Medicine, Volume 44, Issue 5, 399-400, 2019
  • Hamed M, Schraml F Wilson J, Galvin J, Sabbagh MN. Occipital and Cingulate Hypometabolism are Significantly Under-Reported on 18-Fluorodeoxyglucose Positron Emission Tomography Scans of Patients with Lewy Body Dementia., Journal of Alzheimers Disease & Parkinsonism, Volume 8, Issue 1, 428, 2018
  • Schmidt MQ, Schraml FV. Absent Cerebellar Circulation With Intact Cerebral Blood Flow on a 99mTc Bicisate "Brain Death" Study., Clinical Nuclear Medicine, Volume 42, Issue 12, 983-984, 2017

Research and Scholarship

Grant Funding Received

  • "Dopamine Transporter (DAT) Density in Post-Traumatic Stress Disorder: A Potential Biomarker for PTSD" - a joint St. Joseph’s Hospital and Medical Center (SJHMC), Barrow Neurologic Institute (BNI), Creighton University School of Medicine, Carl T. Hayden Phoenix Veterans Medical Center and Arizona State University study. Funded with a grant awarded by The Saint Joseph’s Foundation.
  • A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease.
  • A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease (The AMARANTH Study).
  • Phase IIa Trial of Low Dose Radiation Therapy to Reduce Cerebral Amyloidosis in Early Alzheimer’s Dementia.